Ampersand-backed ProtaGene appoints Kaiser as CEO

ProtaGene is a CRO partner for the biopharmaceutical and cell and gene therapy industries.

21 September 2022•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Falfurrias hires Great Hill’s Greg Stewart to help lead tech, services deals

3 November 2026 · 1 min read

EIV’s Kristin Kelly: From aspiring vet to energy investor

3 November 2026 · 5 mins read

Permira hires former S&P Global CEO Douglas Peterson as senior adviser

2 November 2026 · 2 mins read

o15 Capital Partners hires Capital One’s Rochelle Probst as managing director

29 October 2026 · 1 min read

HighPost Capital hires Quail Ridge founder Ron Sylvestri as managing director, marketing

28 October 2026 · 1 min read

Broad Sky Partners hires ex-Partners Group investor Henry Elefter as managing director

28 October 2026 · 2 mins read

HarbourVest names ex-Hamilton Lane executive Peter Larsen head of infrastructure distribution

27 October 2026 · 1 min read